It was from this corporate office of the Hyderabad-based pharmaceutical firm that a consignment of a Fentanyl precursor was ...

Mark Roy Anderson, 70, took steps to assure potential investors that he “was not the ‘Mark Roy Anderson’ with multiple prior ...

Evolving regulations in sterile manufacturing requires innovation, market knowledge, and investment. How can drug ...

As the trend towards the international dispersion of certain value chain activities produces challenges, discover policies to meet these ...

After getting its hands on a massive Quebecois manufacturing plant from Sandoz in 2022, French CDMO Delpharm is making good ...

Artificial intelligence continues stirring things up in chemistry. To wit: Y Combinator-backed Cambridge, U.K.-based ...

We would like to use cookies to collect information about how you use ons.gov.uk. We use this information to make the website work as well as possible and improve our services.

The EoIs have been floated by the department of pharmaceuticals, under the ministry of chemical and fertilizers for its scheme called Promotion of Research and Innovation in Pharma MedTech Sector ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

The deal involves an upfront cash payment of $4.10 per share, totaling up to $355 million, with additional potential payouts based on milestones. The acquisition strengthens Sun Pharma's innovative ...